161 related articles for article (PubMed ID: 17869249)
1. The PPARdelta agonist, GW501516, promotes fatty acid oxidation but has no direct effect on glucose utilisation or insulin sensitivity in rat L6 skeletal muscle cells.
Dimopoulos N; Watson M; Green C; Hundal HS
FEBS Lett; 2007 Oct; 581(24):4743-8. PubMed ID: 17869249
[TBL] [Abstract][Full Text] [Related]
2. Activation of peroxisome proliferator-activated receptor-{delta} by GW501516 prevents fatty acid-induced nuclear factor-{kappa}B activation and insulin resistance in skeletal muscle cells.
Coll T; Alvarez-Guardia D; Barroso E; Gómez-Foix AM; Palomer X; Laguna JC; Vázquez-Carrera M
Endocrinology; 2010 Apr; 151(4):1560-9. PubMed ID: 20185762
[TBL] [Abstract][Full Text] [Related]
3. Role of AMP kinase and PPARdelta in the regulation of lipid and glucose metabolism in human skeletal muscle.
Krämer DK; Al-Khalili L; Guigas B; Leng Y; Garcia-Roves PM; Krook A
J Biol Chem; 2007 Jul; 282(27):19313-20. PubMed ID: 17500064
[TBL] [Abstract][Full Text] [Related]
4. Angiopoietin-like 4 mediates PPAR delta effect on lipoprotein lipase-dependent fatty acid uptake but not on beta-oxidation in myotubes.
Robciuc MR; Skrobuk P; Anisimov A; Olkkonen VM; Alitalo K; Eckel RH; Koistinen HA; Jauhiainen M; Ehnholm C
PLoS One; 2012; 7(10):e46212. PubMed ID: 23056264
[TBL] [Abstract][Full Text] [Related]
5. Direct activation of glucose transport in primary human myotubes after activation of peroxisome proliferator-activated receptor delta.
Krämer DK; Al-Khalili L; Perrini S; Skogsberg J; Wretenberg P; Kannisto K; Wallberg-Henriksson H; Ehrenborg E; Zierath JR; Krook A
Diabetes; 2005 Apr; 54(4):1157-63. PubMed ID: 15793256
[TBL] [Abstract][Full Text] [Related]
6. PPARδ activation in human myotubes increases mitochondrial fatty acid oxidative capacity and reduces glucose utilization by a switch in substrate preference.
Feng YZ; Nikolić N; Bakke SS; Boekschoten MV; Kersten S; Kase ET; Rustan AC; Thoresen GH
Arch Physiol Biochem; 2014 Feb; 120(1):12-21. PubMed ID: 23991827
[TBL] [Abstract][Full Text] [Related]
7. Dissociation between PGC-1alpha and GLUT-4 expression in skeletal muscle of rats fed a high-fat diet.
Higashida K; Higuchi M; Terada S
J Nutr Sci Vitaminol (Tokyo); 2009 Dec; 55(6):486-91. PubMed ID: 20086318
[TBL] [Abstract][Full Text] [Related]
8. Increased levels of peroxisome proliferator-activated receptor gamma, coactivator 1 alpha (PGC-1alpha) improve lipid utilisation, insulin signalling and glucose transport in skeletal muscle of lean and insulin-resistant obese Zucker rats.
Benton CR; Holloway GP; Han XX; Yoshida Y; Snook LA; Lally J; Glatz JF; Luiken JJ; Chabowski A; Bonen A
Diabetologia; 2010 Sep; 53(9):2008-19. PubMed ID: 20490453
[TBL] [Abstract][Full Text] [Related]
9. Genistein stimulates fatty acid oxidation in a leptin receptor-independent manner through the JAK2-mediated phosphorylation and activation of AMPK in skeletal muscle.
Palacios-González B; Zarain-Herzberg A; Flores-Galicia I; Noriega LG; Alemán-Escondrillas G; Zariñan T; Ulloa-Aguirre A; Torres N; Tovar AR
Biochim Biophys Acta; 2014 Jan; 1841(1):132-40. PubMed ID: 24013029
[TBL] [Abstract][Full Text] [Related]
10. Activation of PPAR-delta in isolated rat skeletal muscle switches fuel preference from glucose to fatty acids.
Brunmair B; Staniek K; Dörig J; Szöcs Z; Stadlbauer K; Marian V; Gras F; Anderwald C; Nohl H; Waldhäusl W; Fürnsinn C
Diabetologia; 2006 Nov; 49(11):2713-22. PubMed ID: 16960684
[TBL] [Abstract][Full Text] [Related]
11. Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome.
Tanaka T; Yamamoto J; Iwasaki S; Asaba H; Hamura H; Ikeda Y; Watanabe M; Magoori K; Ioka RX; Tachibana K; Watanabe Y; Uchiyama Y; Sumi K; Iguchi H; Ito S; Doi T; Hamakubo T; Naito M; Auwerx J; Yanagisawa M; Kodama T; Sakai J
Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15924-9. PubMed ID: 14676330
[TBL] [Abstract][Full Text] [Related]
12. Oral administration of a PPAR-delta agonist to rodents worsens, not improves, maximal insulin-stimulated glucose transport in skeletal muscle of different fibers.
Cresser J; Bonen A; Chabowski A; Stefanyk LE; Gulli R; Ritchie I; Dyck DJ
Am J Physiol Regul Integr Comp Physiol; 2010 Aug; 299(2):R470-9. PubMed ID: 20538899
[TBL] [Abstract][Full Text] [Related]
13. PPARδ agonists have opposing effects on insulin resistance in high fat-fed rats and mice due to different metabolic responses in muscle.
Ye JM; Tid-Ang J; Turner N; Zeng XY; Li HY; Cooney GJ; Wulff EM; Sauerberg P; Kraegen EW
Br J Pharmacol; 2011 Jun; 163(3):556-66. PubMed ID: 21265823
[TBL] [Abstract][Full Text] [Related]
14. PPARdelta activator GW-501516 has no acute effect on glucose transport in skeletal muscle.
Terada S; Wicke S; Holloszy JO; Han DH
Am J Physiol Endocrinol Metab; 2006 Apr; 290(4):E607-11. PubMed ID: 16278250
[TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidylcholines activate PPARδ and protect human skeletal muscle cells from lipotoxicity.
Klingler C; Zhao X; Adhikary T; Li J; Xu G; Häring HU; Schleicher E; Lehmann R; Weigert C
Biochim Biophys Acta; 2016 Dec; 1861(12 Pt A):1980-1992. PubMed ID: 27697477
[TBL] [Abstract][Full Text] [Related]
16. Triglyceride:high-density lipoprotein cholesterol effects in healthy subjects administered a peroxisome proliferator activated receptor delta agonist.
Sprecher DL; Massien C; Pearce G; Billin AN; Perlstein I; Willson TM; Hassall DG; Ancellin N; Patterson SD; Lobe DC; Johnson TG
Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):359-65. PubMed ID: 17110604
[TBL] [Abstract][Full Text] [Related]
17. In vitro responsiveness of human muscle cell peroxisome proliferator-activated receptor δ reflects donors' insulin sensitivity in vivo.
Ordelheide AM; Heni M; Thamer C; Machicao F; Fritsche A; Stefan N; Häring HU; Staiger H
Eur J Clin Invest; 2011 Dec; 41(12):1323-9. PubMed ID: 21615395
[TBL] [Abstract][Full Text] [Related]
18. Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle.
Al-Khalili L; Bouzakri K; Glund S; Lönnqvist F; Koistinen HA; Krook A
Mol Endocrinol; 2006 Dec; 20(12):3364-75. PubMed ID: 16945991
[TBL] [Abstract][Full Text] [Related]
19. The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells.
Dressel U; Allen TL; Pippal JB; Rohde PR; Lau P; Muscat GE
Mol Endocrinol; 2003 Dec; 17(12):2477-93. PubMed ID: 14525954
[TBL] [Abstract][Full Text] [Related]
20. Genetic downregulation of receptor-interacting protein 140 uncovers the central role of Akt signalling in the regulation of fatty acid oxidation in skeletal muscle cells.
Constantinescu S; Turcotte LP
Exp Physiol; 2013 Feb; 98(2):514-25. PubMed ID: 22923231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
